Compass Pathways plc - ADR (5Y6)
Munich
Delayed Data
Oct 19, 2026, 06:00 AM
Day's Range
9.9052 wk Range
4.32Overview - 5Y6 - Compass Pathways plc - ADR
Key Statistics
Valuation
Enterprise Value
-114.57M
P/E (Trailing)
‪-3.24‬
PEG Ratio
‪-0.0090‬
Price / Book
‪15.97‬
EV / EBITDA
‪0.68‬
Profitability
Return on Assets
‪-136.84%‬
Return on Equity
‪544.69%‬
Ownership
Shares Outstanding
134.94M
Price stats
50-Day Avg
‪11.75‬
200-Day Avg
‪8.91‬
Peers - 5Y6 - Compass Pathways plc - ADR
Peer Comparison
Compared with companies in Medical Care Facilities listed on Munich.
- 5Y6MunichCompass Pathways plc - ADR+41.50%52-week change-3.25P/E (Trailing)—Profit Margin
- HTWMunichNational HealthCare Corp.+50.00%52-week change27.03P/E (Trailing)‪8.99%‬Profit Margin
- HCQMunichAMN Healthcare Services, Inc.+53.06%52-week change-14.52P/E (Trailing)‪28.34%‬Profit Margin
- RMYMunichRamsay Health Care Limited+47.35%52-week change24.96P/E (Trailing)—Profit Margin
- 5XEMunichExtendicare Inc.+46.78%52-week change15.11P/E (Trailing)—Profit Margin
- 1ZUMunichThe Pennant Group Inc+43.72%52-week change42.56P/E (Trailing)‪13.77%‬Profit Margin
- 7ATMunichAttendo AB (publ)+41.52%52-week change2.00P/E (Trailing)‪45.31%‬Profit Margin
Profile Summary - 5Y6 - Compass Pathways plc - ADR
About
Compass Pathways plc - ADR is a clinical-stage biotechnology company focused on mental health care. Compass Pathways develops COMP360, a proprietary synthetic psilocybin therapy being studied for treatment-resistant depression and other psychiatric conditions, including post-traumatic stress disorder and anorexia…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
